Medtech Companies Must Adjust To Growth Of Outpatient Centers, ZS Consultant Advises
The medtech industry has been slow to adapt to the rapid growth of lower-cost outpatient centers that are taking procedures out of hospitals, according to Brian Chapman, a consultant for ZS.
You may also be interested in...
In this special podcast from Medtech Insight, editor Reed Miller talked to Andrie Leday, the US vice president for ambulatory surgery centers (ASCs) at Johnson & Johnson/DePuy Synthes. Leday's group is dedicated to creating a new "ecosystem" around DePuy Synthes' broad range of orthopedic implants and tools to meet the demand of an aging population.
Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.
In an interview with Medtech Insight, ZS consultant Brian Chapman explains how medtech companies are handling the uncertainties created by the pandemic and how it could change the industry permanently.